The companies receiving warning letters and their products are:
FDA’s action follows a scientific review by the agency in which it examined the published peer-reviewed literature on the co-consumption of caffeine and alcohol; consulted with experts in the fields of toxicology, neuropharmacology, emergency medicine and epidemiology; and reviewed information provided by product manufacturers. FDA also performed its own independent laboratory analysis of these products.